Introduction
Infectious disease can be regarded as a complex multifactorial disease, with both genetic and environmental variation contributing to differing susceptibilities to infection, and differing effects of infection (Chapman and Hill 2012) . Like any other multifactorial disease, the variation in who is infected has been divided into a genetic component and an environmental component, with heritability estimates equivalent to other multifactorial diseases [for example, heritability of malaria in Kenya is 0.25, equivalent to heritability of type 2 diabetes in Scandinavian countries (Mackinnon et al. 2005; Poulsen et al. 1999) ]. Like any other multifactorial disease, both rare and common genetic variations are likely to play a role. Genomewide association studies have been of limited success in identifying alleles that affect infectious disease susceptibility. we might infer from this that most genetic susceptibility is not determined by common alleles effectively assayed by these studies. another complicating factor is that, at present, most GwaSs of infectious disease are either using relatively small cohorts or by combining cohorts from different countries, and correcting for population differences statistically. The effect on the power to detect susceptibility variants, which may have different frequencies in regions with different patterns of LD in different populations, is unclear. For example, a large meta-analysis of over 5,000 cases with severe malaria and almost 7,000 controls established association, at genomewide significance, of only two loci already well-known in the literature, namely HBB (encoding β-globin) and ABO (encoding aBO blood group) (Band et al. 2013) . However, common copy number variation (CNv) and rare variants are not well tagged common alleles at SNPs and are, therefore, not well assayed by current GwaS approaches. analyses of the effect of rare Abstract variability in the susceptibility to infectious disease and its clinical manifestation can be determined by variation in the environment and by genetic variation in the pathogen and the host. Despite several successes based on candidate gene studies, defining the host variation affecting infectious disease has not been as successful as for other multifactorial diseases. Both single nucleotide variation and copy number variation (CNv) of the host contribute to the host's susceptibility to infectious disease. In this review we focus on CNv, particularly on complex multiallelic CNv that is often not well characterised either directly by hybridisation methods or indirectly by analysis of genotypes and flanking single nucleotide variants. we summarise the well-known examples, such as α-globin deletion and susceptibility to severe malaria, as well as more recent controversies, such as the extensive CNv of the chemokine gene CCL3L1 and HIv infection. we discuss the potential biological mechanisms that could underly any genetic association and reflect on the extensive complexity and functional variation generated by a combination of CNv and sequence variation, as illustrated by the Fc gamma receptor genes FCGR3A, FCGR3B and FCGR2C. we also highlight some understudied areas that might prove fruitful areas for further research.
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variants on infectious disease susceptibility have not yet been published, but there is increasing evidence that CNv has an important role.
CNv is simply different numbers of the same DNa sequence across different individuals and includes not only simple deletion and duplications but also more complex multiallelic variation, with copy numbers ranging from 0 to 14, for example, as has been described for the CCL3L1 gene (aklillu et al. 2013; walker et al. 2009 ). CNv can potentially affect phenotype in several different ways. Perhaps the simplest way is due to a gene dosage effect, where increased numbers of the same gene result in increased levels of mRNa and increased levels of protein. However, CNv can also create novel fusion genes, alter the distance of a gene from a regulatory element, or alter the number of protein-coding exons within a gene (Fig. 1) . CNvs are just another form of variation, and subject to the same rules of population genetics as other variants. However, it is useful to distinguish CNvs into two categories which are based on mutational origin: non-recurrent and recurrent CNvs. Recurrent and non-recurrent CNvs are likely to have different mutation rates and different evolutionary trajectories.
Non-recurrent CNvs of any size can be generated by mechanisms such as non-homologous end-joining (NHeJ) or fork-stalling and template-switching (FosTes), and, because they are often large, are more likely to affect genes and more likely to have an extremely deleterious phenotypic effect (arlt et al. 2012) . Large deletions, for example, will be rare in the population because negative selection acts to rapidly remove the deletion from the population. Fig. 1 The different possible mechanisms of CNv affecting phenotype. a Gene dosage effect. The CNv affects an entire gene, altering the number of copies of the full gene and altering the total amount of mRNa and protein encoded by the gene. example: β-defensins (Hollox et al. 2003; Jansen et al. 2009 ). b Position effect. The CNv affects the distance between a regulatory element and the gene. The regulatory element can be either an enhancer or a repressor, or affect tissue specificity. example: HoxD in mouse (Montavon et al. 2012) . c Fusion gene. a deletion caused by unequal crossing over between the two copies of DNa sequence results in a fusion gene. If the genes on copy 1 and copy 2 are identical, this will have no effect, but if they have diverged in sequence or regulation the new fusion gene may have novel effects. example: butyrophilin-like genes (aigner et al. 2013) . d extra protein coding domains. variation in the number of tandem repeats of coding exons within a gene alters the number of functional protein domains, and final size of the protein. example: complement receptor 1 (wong et al. 1989) Recurrent infections are sometimes a symptom of multiple congenital abnormalities caused by a large chromosomal deletion. For example, patients with 22q11.2 deletion syndrome (OMIM #611867) often have recurrent infections due to low T cell levels (McLean-Tooke et al. 2008) , and patients with 16p12.2-p11.2 deletion syndrome (OMIM #613604) have recurrent ear infections (Okamoto et al. 2014) . There are also examples of rare small deletion alleles that segregate within a family, collectively known as Mendelian infectious susceptibility disease syndromes. For example, a small deletion (4 bp) in the IFNGR1 gene leads to dominant susceptibility to mycobacterial infection (Jouanguy et al. 1999) .
Recurrent multiallelic CNv is generated by non-allelichomologous recombination (NaHR) between segmental duplications. These regions of segmental duplication are non-randomly distributed in the genome and are particularly frequent in subtelomeric and pericentromeric regions, although they occur elsewhere in the genome . These regions are difficult to assemble and often are associated with gaps in the reference genome assembly. The segmental duplications, sometimes in multiple copies, sponsor extensive NaHR and can harbour a large amount of CNv (alkan et al. 2009; Redon et al. 2006) . Importantly, such regions can also harbour extensive sequence variation in the form of paralogous sequence variants (PSvs), which are differences between segmental duplications. Many of these segmental duplication-rich regions arose in the ancestor of great apes (Locke et al. 2003; Marques-Bonet et al. 2009; She et al. 2006 ) and diverged at a rate determined by a balance of new nucleotide substitution mutations occurring on either paralogue and the sequence-homogenising effect of gene conversion (Teshima and Innan 2004) . Recurrent NaHR between these paralogues can shuffle these variants as well as generate CNv, and both copy number and sequence variation can contribute to diversity within these CNvs, which tend to be multiallelic and are sometimes associated with other polymorphic rearrangements such as inversions.
In this review we will focus on common multiallelic CNv where alleles are present at polymorphic frequencies within populations. Studies of complex multiallelic CNvs have shown that the mutation rate is high, several orders of magnitude higher than for single nucleotide polymorphisms, usually because of recurrent NaHR (abu Bakar et al. 2009; Fu et al. 2010; Lam and Jeffreys 2006) . This has two consequences: first CNvs can accumulate variation under mutation-drift balance resulting in a particular DNa sequence having a high level of standing variation and, therefore, a substrate for subsequent selection. Second, if the copy number allele is deleterious then, under mutationselection balance, the strength of negative selection has to be stronger to remove a deleterious allele at a locus that has a higher mutation rate. If the negative selection is mild, or perhaps episodic, then a deleterious copy number allele might reach appreciable allele frequencies. This high mutation rate recurrently generating copy number alleles also can explain why multiallelic CNvs are not well tagged, or at least consistently tagged, by alleles at flanking SNPs. For an overview see (Locke et al. 2006 ) and for particular examples see (Hardwick et al. 2011; Hollox et al. 2009 ) but also see (Hardwick et al. 2014; Khan et al. 2013 ) as examples of multiallelic CNvs tagged by flanking SNPs.
In this review we aim to give an overview of the evidence that human host CNv affects susceptibility to infectious disease. Table 1 summarises the larger studies undertaken so far, and in the text we focus on the more well-established examples, as well as suggesting avenues for further research.
Host copy number variation and malaria
The most well-known example of copy number variation affecting infectious disease susceptibility is that of the α-globin genes HBA1 and HBA2. α-Globin is copy number variable, with most individuals having four copies per diploid genome, two copies of HBA1 and two copies of HBA2. Homozygotes for α-globin deletion alleles (two copies per diploid genome) have α + -thalassemia and individuals with one or two copies of duplications having no clinical phenotype (Harteveld and Higgs 2010) . The diploid copy number of α-globin can be related to distinct clinical features, as shown in Fig. 2 , with a clear gene dosage effect: the fewer the genes, the more severe the symptoms.
The frequency of alleles with three HBA genes is low in most populations (typically <1 %, although 5 % in Greek Cypriots) (Goossens et al. 1980; Liu et al. 2000) . However, the frequency of HBA deletions and alleles of even lower copy number are frequent in populations with endemic malaria, for example in non-malaria regions HBA deletion alleles are at a frequency of ~1 %, while in malaria regions such as sub-Saharan africa the frequency can reach 20 %. This is due to the protective effects of the deletion allele against severe malaria [ Table 1 , (May et al. 2007; Mockenhaupt et al. 2004; . The α-globin locus is the only frequently polymorphic CNv where direct measures of mutation rate have been made using sperm. These suggest a mutation rate of 4.2 × 10 −5 per sperm, which would predict a higher frequency than 1 % in northern europeans. This discrepancy is likely to be due to selection against the deletion allele in non-europeans for a phenotype other than α + thalassemia, which itself is often asymptomatic (Lam and Jeffreys 2006) .
Two loci encoding receptors used by Plasmodium falciparum to gain entry into erythrocytes are also known to be Larsen et al. (2012) copy number variable. The first, complement receptor 1 (CR1), shows copy number variation within the gene such that different alleles have different numbers of Long Homologous Repeats (LHRs), which encode 30 kDa extracellular domains involved in complement C3 binding (Dykman et al. 1983; Stoute 2011; vik and wong 1993) . Four CR1 alleles have been described with 3, 4, 5 or 6 LHR domains, with the 4 LHR domain allele (CR1*F) being most frequent, at least in europeans. The region of CR1 critical for P. falciparum erythrocyte invasion is within the N-terminal region of the protein, which is outside the copy number variable region of the gene (Park et al. 2014; Tham et al. 2010 ). However, the crystal structure of the receptor is not known and it is perhaps likely that higher numbers of the large LHR domains will interfere with the interaction with P. falciparum. Several SNPs within and surrounding CR1, including those responsible for the Knops blood group alleles (Moulds 2010) , have been tested for association with various malaria clinical phenotypes, with inconsistent results (Thathy et al. 2005; Zimmerman et al. 2003) .
None has, to our knowledge, assessed the effect of CR1 CNv.
The second locus includes the glycophorins GYPA, GYPB, and GYPE which are arranged as three tandem repeats of between 100 and 140 kb in size with about 97 % sequence identity. all three proteins are expressed on the surface of erythrocytes, and GYPa is a receptor for P. falciparum via erythrocyte-binding-antigen-175 (Duraisingh Tolia et al. 2005) . extensive copy number variation of this region has been discovered in several genomewide surveys (Table 2 ), but the nature and phenotypic consequences of this variation, particularly in terms of resistance to malaria, remain to be determined.
Host copy number variation and HIV
Genetic variation plays an important role in several clinical phenotypes related to infection by human immunodeficiency virus-1 (HIv-1), such as susceptibility to infection, time from infection to development of aIDS and viral load levels at clinical latency (known as set point viral load) (Shea et al. 2013 ). a canonical example of this, and indeed a key example of a common variant having a strong effect on disease, is the CCR5Δ32 allele. This 32 bp polymorphic deletion disrupts the reading frame of CCR5, which encodes the principal co-receptor for HIv, and has been associated with protection from HIv infection and a longer time from infection to aIDS (Carrington et al. 1999) .
The first complex CNv to be associated with HIv-1 susceptibility involved the genes CCL3L1 and CCL4L1. a large study on both horizontal transfer (adult-adult) and vertical transfer (mother-child) of HIv-1 suggested that higher copy number of CCL3L1 led to protection against HIv-1 infection, and a lower copy number led to susceptibility to HIv-1 infection (Gonzalez et al. 2005) . The association was attractive, since CCL3L1 and CCL4L1 encode MIP1-α and MIP1-β, both ligands for CCR5, and could possibly compete with HIv-1 in occupying the CCR5 receptor. However, attempts to replicate the data have been inconsistent, with several large studies failing to replicate the data (Table 1) (Bhattacharya et al. 2009; Lee et al. 2010 ). a recent meta-analysis of nine studies supported an association of lower CCL3L1 with susceptibility to HIv (Liu et al. 2010) , but this study did not critically analyse the quality of the published data used in the meta-analysis. The difficulty in establishing a link between CCL3L1 copy number and HIv-1 infection status is due to three related issues. First, and perhaps most importantly, is the importance of the most accurate and precise estimates of diploid copy number for each individual in a cohort. This is important because we generally expect genetic effects to be small, and they are likely to be much smaller than effects due to noise or systematic bias of an assay. Noisy assays will generally lead to false negative results, because the small effect is swamped by random noise. Second, systematic bias in a study, either due to population stratification effects or technical biases (for example, assaying controls and cases in separate experiments), will increase the false positive rate as such biases will be interpreted as a real genetic effect. The strengths and weakness of different assays for CCL3L1 copy number have been extensively discussed elsewhere (Cantsilieris and white 2013) , and, importantly, these issues apply to all other multiallelic loci discussed in this review. Most studies show that, of highthroughput PCR-based assays, a form of quantitative PCR called the paralogue ratio test [PRT, (armour et al. 2007; walker et al. 2009 ), Fig. 3b ] performs best, with digital droplet PCR also producing some promising results [(Hindson et al. 2011) , Fig. 3a] . The third issue is the poor understanding we have of the exact structure of the variation underlying the CCL3L1 CNv. The consensus is that CCL3L1 and CCL4L1 are on a single copy number variable unit of around 90 kb, which is tandemly repeated. This is supported by complete concordance of CCL3L1 and CCL4L1 copy number, as measured by PRT in europeans (walker et al. 2009 ). Such a structure is supported by fibre-FISH analysis of one european and one Yoruba individual (Perry et al. 2008 ). However, both fibre-FISH and PRT suggest a more complex structure in other sub-Saharan africans (aklillu et al. 2013) . In a Yoruba trio, a copy number allele comprised tandem copies of repeat units, some of which were larger and carrying the neighbouring TBC1D3 gene. an alternative assembly of this region in provided by the Genome Reference Consortium in GRC38 supports this observation. In ethiopians, PRT suggested that rare alleles in the population showed discordance between CCL3L1 and CCL4L1 copy number, reflecting further complexity, but unfortunately cells were not available from these individuals for fibre-FISH analysis (aklillu et al. 2013) .
an important clinical phenotype of HIv infection is the response to antiretroviral drugs, particularly given the implementation of highly active antiretroviral therapy (HaaRT) to high-prevalence areas in africa. Immune reconstitution, as it is called, following initiation of HaaRT varies between different people both in speed of CD4 recovery and final CD4 cell levels. Copy number of CCL3L1, together with a particular CCR5 haplotype, was shown to affect immune reconstitution in europeanamericans and african-americans (ahuja et al. 2008 ). However, a large study on therapy-naive patients in africa showed that CCL3L1 affected immune reconstitution, but in the opposite way to the previous study, with individuals of low CCL3L1 copy number showing an increased speed of CD4+ recovery (aklillu et al. 2013) . Therefore, the role and possible mechanism of CCL3L1 in immune 
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Paralogue ratio test (PRT) Fig. 3 Two robust PCR-based methods to measure CNv. a Digital droplet PCR. This approach uses two TaqMan assays to detect presence of CNv and/or reference loci in emulsion droplets after emulsion PCR amplification. The thousands of droplets are effectively miniaturised PCR reactions, with the genomic DNa at limiting dilution such that most droplets will not contain a DNa molecule that can be amplified by the CNv or reference primers. b Paralogue ratio test (PRT). This approach uses carefully designed primers that amplify a region within the CNv of interest but also at a diploid reference control locus. Such primers are often targeted to diverged repeat elements, and the products amplified from the reference and CNv need to be distinguished by size, so that they can be detected by capillary electrophoresis and quantified. In practice, at least two PRTs are designed per CNv locus, and positive controls of known copy number used to normalise for variation between experiments 1 3 reconstitution remains unclear. Furthermore, the role of copy number variation at genes involved in the metabolism of drugs [for example CYP2D6, (Bertilsson et al. 1993; Lundqvist et al. 1999) ] in immune reconstitution has not been examined and may be an interesting and important avenue to explore. a similar paradox has been uncovered for a potential association of β-defensin copy number and HIv-1 viral load and immune reconstitution. β-defensins are small peptides that have been shown to have antimicrobial and antiviral properties, including anti-HIv activity. a cluster of β-defensins are copy number variable as a block, with copy number commonly ranging from 2 to 8 copies (Hollox et al. 2008a ). we might expect that higher copy number of an antiviral peptide would result in a lower HIv viral load and improved immune reconstitution, but the opposite appears to be the case (Hardwick et al. 2012) . we can reconcile this result with the fact that several β-defensins, hBD-2 (encoded by the DEFB4 gene) in particular, have chemoattractant activities to a variety of cells including dendritic cells (Yang et al. 1999 ) and Th-17 cells (Ghannam et al. 2011 ). This might allow HIv-1 to establish infection foci more effectively in individuals with higher copy number, and, therefore, higher levels of hBD-2 protein.
Furthermore, unlike the chemoattractant activity of hBD2 (typically at 25-100 ng/ml), the anti-HIv-1 activity of hBD2 is only at unphysiological concentrations (>4 µg/ml) (Quiñones-Mateu et Sun et al. 2006) . This is in contrast to physiological levels of hBD2 in serum and vaginal fluid of less than 10 ng/ml in healthy and infected conditions and <150 ng/ml in serum from inflammatory disease patients (Jansen et al. 2009; Jiang et al. 2012; Mitchell et al. 2013 ). This casts doubt on the role of hBD2 as an antiviral molecule in vivo.
The best-established role of CNv in HIv-1 infection remains that of killer-cell immunoglobulin-like receptor gene family (KIRs), members of which are expressed by natural killer cells and encoded by a gene cluster on chromosome 19 (Middleton and Gonzelez 2010) . They bind to the major histocompatibility complex (MHC) class I ligands on the surface of target cells and mediate either an inhibitory or activatory response by NK cells depending on the exact nature of the KIR. There are two main haplotypes of the KIR gene cluster, termed a and B, characterised by different complements of KIR genes. within the B haplotype, there is further extensive variation in gene content and copy number, the functional consequences of which remain unclear. There has been a particular focus on the KIR3DS1 gene which binds the MHC molecule encoded by the HLa Bw6 antigen (encoded by particular alleles of the HLa-B locus). The presence of a particular KIR gene, KIR3DS1, in combination with a particular allele at HLa-B (Bw4-80I) significantly slows progression to aIDS. Furthermore, this effect is dependent on the copy number of KIR3DS1, with increased copies (in combination with a HLa-Bw4-80I allele) showing lower levels of HIv-1 viral load in clinical latency phase (alter et al. 2007; Bashirova et al. 2011; Pelak et al. 2011) . This is an interesting example of epistasis, where the effect of one allele is dependent on the presence of another allele at a physically unlinked locus. It may be the case that similar epistatic effects between copy number variable ligands and receptors exist.
Host copy number variation and other infectious diseases
HIv and malaria are the infectious diseases about which most research has been done and most is known. However, other studies of host CNv and infectious disease have shown interesting results, and we discuss some below.
Haptoglobin (HP), a gene encoding an abundant acutephase glycoprotein in the plasma, is one of the earliest blood serum proteins identified with copy number variation (CNv), carrying two alleles namely Hp1 and Hp2, spanning a 1.7-kb intragenic duplication region in such a way that the Hp2 allele encodes a longer peptide chain than the Hp1 allele (Maeda et al. 1983 (Maeda et al. , 1986 . HP shares ~94 % sequence similarity with a neighbouring gene, haptoglobinrelated protein [HPR, (Hardwick et al. 2014; Maeda et al. 1986) ]. The two genes originated in a triplication in Old world Monkeys resulting in three genes HP, HPR and HPP (haptoglobin primate) (Mcevoy and Maeda 1988) . all three genes are observed in extant Old world Monkeys and apes, except humans, who have lost the HPP gene after divergence from chimpanzees. In humans, HPR shows CNv between 2 and 4 copies per diploid genome, although an early study suggested rare copy numbers as high as 7 per diploid genome. The tandemly arranged copies have been derived from a non-allelic homologous recombination event (NaHR) 1 kb 3′ to the genes so that the new copies are essentially identical to HPR and are not an HP-HPR fusion gene (Maeda et al. 1986 ).
Haptoglobin protein (Hp) binds to the free haemoglobin (Hb) released by lysis of erythrocytes as a result of acute infection. The Hp-Hb complex is then cleared by binding to the macrophage scavenger receptor CD163, followed by endocytosis. Like Hp, haptoglobin-related protein (Hpr) binds with free heme, but the Hpr-Hb complex binds to apoL1 instead and forms part of the trypanolytic lytic factor (TLF) providing innate immunity against trypanosomes (Nielsen and Moestrup 2009; vanhollebeke et al. 2008) . It is, therefore, conceivable that both HP and HPR gene copy number variations have experienced selection pressure in response to pathogens (Iskow et al. 2012; McDermid and Prentice 2006) . The Hp2 allele has been suggested to protect against severe malaria (atkinson et al. 2006) , but this has not been supported (aucan et al. 2002; Cox et al. 2007) , and there is no correlation between allele frequency and malarial endemicity, unlike alleles at other genes that are protective against malaria, such as the sickle-cell haemoglobin allele (Hardwick et al. 2014 ). There is suggestive evidence that duplication of the HPR gene is protective against human african trypanosomiasis (HaT), and the population distribution of the HPR duplication mirrors the distribution of Trypanosoma brucei gambiense, which causes HaT. However, the duplication allele is at modest frequency (10 %) even in HaT endemic areas and there is no evidence for recent direction selection (Hardwick et al. 2014; Rodriguez et al. 2012) .
Fcγ receptors are the cell-surface receptors for immunoglobulin G (IgG), which is the most abundant Ig class in serum, constituting more than 75 % of circulating immunoglobulin complex. They are expressed on various leucocytes, show extensive CNv and are categorized into three main classes: FcγRI, FcγRII and FcγRIII (Nimmerjahn and Ravetch 2008) .
FcγRI is a high-affinity Fcγ receptor for monomeric IgG, with three highly similar genes (>95 % identity) assembled in the human reference genome (FCGR1A, FCGR1B and FCGR1C) (ernst et al. 1992; Maresco et al. 1996; van der Poel et al. 2011) . The copy number of these genes has increased in the human lineage and shows copy number variation between individuals (Sudmant et al. 2010) . all three genes are within the pericentromeric region of chromosome 1, and the human-specific copy number increase is likely to be associated with a pericentromeric inversion that distinguishes human chromosome 1 from chimpanzee chromosome 1 (Maresco et al. 1998) . The functional differences between the variants remain unclear: FCGR1A encodes a membrane-bound high-affinity IgG receptor, and FCGR1B and FCGR1C are predicted 
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NAHR resulting in inappropriate expression of genes Example, FCGR2B expression on NK cells from deleted alleles, probably due to increased proximity of NK-specific enhancer.
NAHR resulting in duplication of genes with increase in gene expression Example, FCGR3A and FCGR2C duplication (predicted).
NAHR at alternative breakpoint resulting in duplication of genes Example, FCGR3B and FCGR2C duplication (predicted). and FCGR3B, and a FCGR2C fusion gene. This has been the substrate for further complex copy number and sequence variation at this locus, examples indicated by different numbers. all these have been observed and published (cited in the text), with the exception of the structure of the known duplicated alleles (examples 6 and 7) which is predicted as the reciprocal of the deletion structure following NaHR to encode soluble forms of the receptor, without a membrane spanning region. However, only FCGR1A has been shown to be definitely functional (van vugt et al. 1999) . Studies of knockout mice show that FcγRI protects against Bordetella pertussis, the causative agent of whooping cough (Ioan-Facsinay et al. 2002) , and the entry of E.coli K1 into macrophages in neonatal meningitis is mediated by FcγRI (Mittal et al. 2010) . Some studies have suggested the involvement of FcγRI in the pathogenesis of dengue fever (Chawla et al. 2013; Rodrigo et al. 2006 Rodrigo et al. , 2009 , and there is convincing evidence that FcγR1 mediates antibodybased protection against Plasmodium falciparum malaria ( McIntosh et al. 2007) . However, although shown to be a human-specific CNv, with multiple copies, because the genes are within a complex pericentromeric region of chromosome 1 characterisation of the variation is challenging and the nature of the CNv, and its relationship with disease, remains unknown. FCGR2 and FCGR3 genes encode low-affinity Fcγ receptors, FcγRII and FcγRIII, respectively, which bind to IgG-antigen immune complexes, and initiate either inhibitory or activatory signalling responses within the cell, depending on the type of receptor engaged (willcocks et al. 2009 ). The human reference genome assembly shows two copies of the FCGR3 gene, termed FCGR3A and FCGR3B, and three copies of the FCGR2 gene, FCGR2A, FCGR2B and FCGR2C. FCGR3A and FCGR3B are distinguished by a premature stop mutation in FCGR3B which results in a truncated FcγRIIIB receptor without a transmembrane domain, attached to the membrane by a glycophosphatidylinositol anchor (Ravetch and Perussia 1989) . The receptors encoded by FCGR3A and FCGR3B are functionally distinct, with FCGR3B expressed primarily by neutrophils, and FCGR3A expressed in natural killer cells, dendritic cells, monocytes and macrophages. The two FCGR3 genes are on a 82-kb segmental duplication which shares ~98 % sequence identity. FCGR2A and FCGR2B are at either end of the segmental duplications, with FCGR2C a fusion gene of FCGR2A and FCGR2B, spanning the two segmental duplications (Fig. 4) . The segmental duplication is copy number variable, with deletions and duplications at appreciable frequency in different populations (aitman et al. 2006; Hollox et al. 2009) (Fig. 4) , resulting in CNv for FCGR3B, FCGR3A and FCGR2C, but not FCGR2A nor FCGR2B (Breunis et al. 2009; Reilly et al. 1994 ). There is a gene dosage effect for FCGR3B, where expression levels on the cell surface reflect gene copy number (willcocks et al. 2008) . Deletions of FCGR3B also alter the expression pattern of FCGR2B, which itself is not CNv, causing it to be expressed on natural killer cells [(Mueller et al. 2012; van der Heijden et al. 2012) , Fig. 4 example  5) ]. Furthermore, because of the particular structure of the CNv, the copy number of FCGR2C varies in concert with FCGR3B and FCGR3A [(Machado et al. 2012) , Fig. 4 ]. Because CNv of FCGR3B is associated with altered cell expression of FCGR2B and CNv of FCGR2C, it is difficult to determine the cause of an observed association between FCGR3B copy number and disease. Sequence variation within paralogues adds another layer of complexity. For example, FCGR2C is a polymorphic pseudogene, [Gln57Stop, (ernst et al. 2002; Metes et al. 1998) , Fig. 4 example 1] and most copies, at least in europe, are nonfunctional; also, extensive variation within FCGR3B alters its affinity for different IgG classes [(Ory et al. 1989a, b; Salmon et al. 1990) , Fig. 4 example 2] .
The low-affinity Fcγ receptors trigger a number of immuno-regulatory functions, including degranulation, phagocytosis and regulation of antibody production. GwaSs have shown association of SNPs within FCGR2A with susceptibility to Helicobacter pylori and Kawasaki disease (Khor et al. 2011; Mayerle et al. 2013) . However, at present it is unclear whether these associations represent variation within FCGR2A itself, sequence variation within the neighbouring CNv or the CNv itself. Such associations are difficult to disentangle, particularly because of the unclear relationship between copy number variation between flanking SNPs and CNvs. In general, such complex multiallelic CNvs are not well tagged by flanking SNP alleles Locke et al. 2006) , but, given a large enough dataset and a particular CNv mutational history, certain CNv alleles may be partially tagged by flanking SNP alleles or SNP haplotypes.
Both Fcγ receptor regions contain interesting functional candidate genes for infections that undergo antibodydependent enhancement, such as dengue virus (Littaua et al. 1990 ). During dengue infection, the host immune response triggers a mechanism called antibody-dependent enhancement (aDe), whereby a heterotypic antibody (one from previous infection of a different dengue serotype) binds to the virus from the secondary infection but does not neutralize it. The virus then enters the cell like a "Trojan Horse"-forming the virus-antibody immunoglobulin complex, which enters the cell via binding to the Fcγ receptors (Chan et al. 2011; Nimmerjahn and Lux 2014) , and, therefore, creates a phenomenon called "cytokine storm" which ultimately could result in severe form of dengue. Consequently, CNv of Fcγ receptor gene clusters may have a significant impact on dengue severity, possibly via its alteration of gene dosage.
Host CNV and autoimmune disease
Many of the immunity genes that show CNv have been investigated in the context of susceptibility to autoimmune diseases (Olsson and Holmdahl 2012; Schaschl et al. 2009 ).
Perhaps the best established is the CNv of complement C4 within the MHC region at chromosome 6p21.32. a tandemly arranged 33 kb segmental duplication with >99 % sequence identity carries the paralogous genes C4a and C4B, and both genes vary in copy number independently of each other (Belt et al. 1985; Chung et al. 2002; Dykman et al. 1983; Yu et al. 1986 ). Lower copy number of C4 has been identified as a risk factor to several autoimmune diseases, particularly systemic lupus erythematous (SLe) (Yang et al. 2007) .
Other examples of CNvs discussed in this review have also been associated with autoimmune and inflammatory diseases, but results have not been conclusive and often not reproducible. For example, CCL3L1 has become a candidate gene of interest in many autoimmune diseases, including rheumatoid arthritis, SLe and asthma, but these results have not been replicated and doubts have been raised on the accuracy of the methods used for typing this CNv (Carpenter et al. 2011; Lee et al. 2011; Mamtani et al. 2008; McKinney et al. 2008; Nordang et al. 2012 ). a similar story exists for Fcγ receptor gene CNv, although there is more convincing evidence of an association of low FCGR3B copy number with rheumatoid arthritis (Graf et al. 2012; Marques et al. 2010; McKinney and Merriman 2012; Robinson et al. 2012 ) and with SLe (aitman et al. 2006 ). The only large-scale, replicated CNv study so far is the association of high β-defensin copy number with psoriasis (Hollox et al. 2008b; Stuart et al. 2012) .
Identification of CNvs affecting the susceptibility to autoimmune and inflammatory diseases informs study on CNvs and infectious diseases, but we might expect the same loci to be involved. The relationship between genetic variation in infectious disease susceptibility and autoimmune/inflammatory disease is most clear in the MHC region where, for example, the susceptibility allele for inflammatory disease ankylosing spondylitis HLa-B*27 is associated with delayed progression to aIDS in HIvinfected patients (Kaslow et al. 1996; Schlosstein et al. 1973) . In recent GwaSs, an overlap between loci containing susceptibility alleles for Crohn's disease and loci affecting response to pathogens has been identified (Cagliani et al. 2013; Jostins et al. 2012) . Together this points to a fine balance between a strong and appropriate immune response to challenge by a pathogen and an excessive and inappropriate response leading to autoimmune disease (Fig. 5) . Genetic variation at immune genes will alter the fulcrum position of this balance and lead to susceptibility to infectious or inflammatory diseases. It should be remembered that the genes encoding the immune response have evolved in conditions where co-morbidity, particularly with helminths, was the norm. One hypothesis is that removal of helminth infectious burden in modern populations has resulted in an immune system prone to autoimmune disease (Sironi and Clerici 2010) . we would predict that new, derived alleles at immunity genes would be protective against autoimmune disease and susceptible to infectious disease and old, ancestral alleles susceptible to autoimmune disease and protective against infectious disease (Di Rienzo and Hudson 2005) . Support for this model comes from analysis of sequence variation within the FCGR2/3 CNv, where the ancestral HNa1a and FCGR2C*Gln57 variants are associated with helminth diversity across human populations (Machado et al. 2012 ). These two variants have also been associated with susceptibility to ideopathic pulmonary fibrosis (Bournazos et al. 2010 ) and the haematological autoimmune disease idiopathic thrombocytopenic purpura idiopathic, respectively (Breunis et al. 2008) . There is some suggestive evidence that FCGR2C*Gln57 is protective against tuberculosis co-infection in an HIv-infected ethiopian cohort, but this may be confounded by FCGR3B copy number, and the causative allele is unclear (Machado et al. 2013 ).
Summary and challenges
Several studies have associated complex CNv with susceptibility to infectious disease, or another clinical parameter related to infectious disease, such as progression (Table 1) . Taken together, these point to a potentially important role of common CNv in determining an individual's susceptibility and response to infectious disease. Currently, complex CNv studies are focused on a candidate gene approach, which are inherently biased and often yield false positive results. even for candidate genes, accurately typing a single complex CNv is not straightforward. Real-time quantitative PCR approaches, in particular, are generally not robust enough for accurate, precise copy number calling, and many studies accept results from these assays uncritically, without internal controls or validation. Other more robust methods include the paralogue ratio test (PRT) and digital droplet PCR but each has strengths and limitations in terms of cost per sample, amount of DNa used and ease of assay design. In our studies, PRT is cost effective, with assay-design made more straightforward by an online database (veal et al. 2013 ), but extensive validation of each assay, and ideally multiple assays for the same CNv, is still required.
The unbiased assessment of genetic variation using genomewide approaches would be more likely to yield robust reproducible associations, in theory. However, unlike genomewide SNP genotyping, which is very reliable, hybridisation data from SNP chips often cannot reliably type complex copy number variation because of inherent noisiness of SNP hybridisation data and systematic differences between cohorts and batches that are poorly understood. Similar issues affect array comparative genomic hybridisation (Pinto et al. 2011) . The great hope is sequence read-depth mapping from new sequencing technologies, which can yield sequence data and copy number data based on the number of reads that map to a given region on the reference genome (Krumm et al. 2012) . However, this assumes the sequence is actually present in the reference genome, requires high-coverage whole genome data and is computationally intensive.
we might expect such complex CNv loci to be under selection if different copy number alleles affected the susceptibility to infectious disease. For non-CNv regions, methods for testing for the action of selection from population diversity data are well developed, because of the use of the infinite site model, which is an accurate mutation model for single nucleotide polymorphisms, allowing for the development of a robust neutral null model (Nielsen 2005) . For CNv loci, this is not the case, and most analyses have relied on population differentiation statistics as an indicator of selection (Perry et al. 2007; Redon et al. 2006) . Instead of the infinite-sites model, appropriate nullmodels of variation in copy number might be based on the stepwise-mutation model (SMM), which is much used for modelling the neutral behaviour of microsatellites because it can allow for recurrent mutations, but the SMM assumes all copies are equivalent, therefore ignoring sequence differences between copies. Some work has been published using coalescent theory to model sequence variation in a region where a duplicated copy is polymorphic in the population, and there are, therefore, just two CNv alleles: one-copy alleles and two-copy alleles (Teshima and Innan 2012; Thornton 2007 ). a neutral model combining a mutational model of DNa sequence within a CNv together with a mutational model of the CNv itself will be a real advance and a very useful analytical tool and could use either coalescent simulation or forward simulation approaches.
we would also like to call for the continued support of sample collection, particularly in large studies of the epidemiology of infectious disease where the role of host variation can often be overlooked. Both host variation, pathogen variation and environmental variation should be studied together rather than assembling the pieces after the research has been done. we would also support internationalisation of research-no country has a monopoly on methods or expertise, and restricting sharing of data or resources impedes our understanding, to the detriment not only of the researchers but also of individuals with the disease. Nevertheless, we anticipate an exciting future for studying host complex CNv and infectious disease susceptibility: the combination of technical challenge, biological interest and clinical importance is what makes the field of complex CNv so exciting.
